WUXI XDC 02268
82.1000.18%( -0.150 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
WUXI XDC (02268) Major Shareholders - Stakes, Shares Held and Changes - cibo
| Shareholder | |||
|---|---|---|---|
| WuXi Biologics (Cayman) Inc. | 50.72% | 635.48M | |
| WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) | 21.89% | 263.20M | |
| WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) | 14.14% | 179.38M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| Schroders Limited | -2.47M | 83.37 | Sold | 61.61M | 4.85% | ||
| Schroders PLC | +394.50K | 75.66 | Bought | 63.54M | 5.01% | ||
| Schroders PLC | -676.00K | 71.36 | Sold | 63.14M | 4.98% | ||
| STA Pharmaceutical Hong Kong Investment Limited (合全藥業香港投資有限公司) | -53.52M | 73.23 | Sold | 179.38M | 14.14% | ||
| Shanghai SynTheAll Pharmaceutical Co., Ltd. (上海合全藥業股份有限公司) | -53.52M | 73.23 | Sold | 179.38M | 14.14% | ||
| WuXi AppTec (Shanghai) Pharmaceutical R&D Co., Ltd. (藥明康德（上海）醫藥研發有限公司) | -53.52M | 73.23 | Sold | 179.38M | 14.14% | ||
| WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) | -53.52M | 73.23 | Sold | 179.38M | 14.14% | ||
| Morgan Stanley | 48.24M | -- | Ceased to be notifiable | 25.64M | 2.02% | ||
| Schroders PLC | +516.50K | 71.01 | Bought | 63.78M | 5.03% | ||
| Morgan Stanley | 7.14M | -- | Shares pledged | 73.70M | 5.81% | ||
| Schroders PLC | -531.00K | 73.04 | Sold | 63.27M | 4.99% | ||
| Morgan Stanley | 60.37M | -- | Other event | 73.70M | 5.81% | ||
| Schroders PLC | +2.28M | 73.55 | Bought | 63.80M | 5.04% | ||
| Schroders PLC | -2.49M | 77.29 | Sold | 61.52M | 4.86% | ||
| Schroders PLC | 109.00K | 55.40 | Bought | 63.42M | 5.01% |
This page shows the major shareholders of WUXI XDC (02268) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.
